LifeActive Bio

LifeActive Bio is a private, pre-revenue biotech firm founded in 2018, commercializing a novel nano-emulsion delivery platform called XnanodeX™. The technology utilizes GRAS-certified ingredients to form natural lipid nanoparticles capable of transporting molecules larger than 1,000 g/mol, bypassing first-pass metabolism for improved systemic delivery. The company operates primarily as a B2B platform, offering its technology for private label partnerships in the wellness, cosmetic, and nutraceutical sectors, with a long-term vision for therapeutic applications. Its current focus is on scaling through IP licensing rather than developing its own therapeutic pipeline.

XnanodeX™ Nano-Emulsion: A proprietary lipo-surfactant microemulsion that forms natural lipid nanoparticles for enhanced transdermal and oral delivery of molecules >1,000 g/mol, bypassing first-pass metabolism using GRAS ingredients.

LifeActive Bio competes in the broad field of advanced nutrient and drug delivery, facing competition from companies with liposomal, nanoparticle, and other emulsion-based technologies. It differentiates by emphasizing a natural (GRAS) composition, high molecular weight capacity, and multi-format application, but must prove superior efficacy to gain market share against well-funded incumbents.